I'm a biotech executive and scientist with a passion for advancing oncology therapeutics from discovery through clinical development. Over the course of my career, I’ve led R\&D strategy and operations in organizations ranging from early-stage startups to large global pharma, including Takeda, ImmunoGen, Novartis, and Biogen. I’ve had the privilege of building high-performing teams, guiding complex portfolios, and contributing to therapies that make a real difference for patients. Today, I enjoy advising innovative biotech companies and VCs as they shape the next generation of cancer treatments.

After more than 30 years navigating and shaping the biotech, pharmaceutical, and life sciences landscape, I’ve reflected on my journey across commercial, operational, and scientific leadership. From purifying biologics at Cetus to closing multi-million-dollar informatics deals, I’ve remained focused on delivering strategic, human-centered solutions. Here is my biography.

Kasey Konkey is a seasoned executive with over 20 years of experience leading global operations and customer success in the software and life sciences industries. Renowned for her ability to align cross-functional teams with strategic business goals, she has consistently delivered transformative results—boosting revenue, improving margins, and enhancing client satisfaction. With a strong foundation in project management, operational leadership, and client engagement, Kasey thrives in dynamic environments, guiding complex initiatives from concept to completion. Her integrity-driven leadership, paired with deep technical knowledge and a collaborative communication style, makes her a trusted advisor to both internal teams and executive stakeholders.

After nearly four decades in the healthcare and life sciences industries, I’ve taken time to reflect on the incredible journey, the lessons learned, and the impact made. From digital imaging to executive leadership, from Canada to South America, I’ve had the privilege of building teams, growing businesses, and helping others achieve their goals. Here is my biography.

I'm excited to share my executive biography, which reflects over two decades of work in vaccine innovation, strategic investment, and scientific leadership across global biopharmaceutical landscapes. This journey has been rooted in a passion for transforming complex science into real-world solutions.

After a fulfilling career that has taken me around the world and across some of the most respected names in biotech and pharmaceuticals, I’m proud to share this executive biography that captures my professional journey, passions, and commitment to improving patient outcomes.

Marianne Savage is a seasoned technology executive and life sciences strategist with a distinguished career leading enterprise innovation across regulated industries. With over 40 years of experience spanning global product management, pharmacovigilance, and go-to-market strategy, she has played a pivotal role in transforming legacy systems into modern, cloud-based platforms that meet stringent compliance standards. Marianne’s ability to blend deep regulatory knowledge with technical fluency and operational leadership has earned her a reputation as a trusted advisor, team builder, and driver of strategic growth.

After nearly three decades of experience across the pharmaceutical and life sciences industries, I’m proud to share my executive biography. From commercial launches to global partnerships, keynote speaking, and team leadership, I’ve been fortunate to work with some incredible people and companies, all driven by a common mission: improving lives through innovative medicine.

I’m excited to share my professional executive biography, which reflects over 20 years of experience in biotech, food safety, and technical sales. I’ve led organizations, built market strategies, and supported international teams, and now I’m looking forward to applying those lessons through advisory or board leadership roles.

Dr. Michael E. Kuligowski, MD, PhD, MBA, is a globally recognized physician-executive with over four decades of leadership in dermatology, clinical development, and pharmaceutical strategy. With a distinguished career spanning Europe and the United States, he has led the development and approval of numerous dermatologic therapies, including Opzelura® for atopic dermatitis and vitiligo. Known for his scientific rigor, strategic foresight, and collaborative leadership, Dr. Kuligowski continues to influence the future of dermatologic innovation through executive roles, advisory board appointments, and pro-bono consulting in the life sciences sector.

Dr. Larrye Ellis Loss, PharmD, MBA, is a global pharmaceutical executive and consultant with over 40 years of experience leading clinical development, medical affairs, and strategic operations across the life sciences industry. With a distinguished career at AstraZeneca and current advisory work through his own consultancy, Larrye brings deep expertise in drug development, regulatory strategy, and cross-functional leadership. He is known for his integrity, global perspective, and commitment to mentoring the next generation of healthcare professionals. Passionate about service, he also dedicates his time to nonprofit leadership and disaster relief with the American Red Cross.

Lain Anderson is a seasoned leader in healthcare consulting, serving as Managing Director and Co-Head of the Americas Healthcare Sector at L.E.K. Consulting. With nearly two decades of experience advising global biopharma and life sciences companies, he specializes in corporate growth strategy, product commercialization, portfolio prioritization, and investment decision-making. Known for his strategic insight and collaborative approach, Lain helps organizations navigate the intersection of science, market opportunity, and financial performance. His background includes roles at Alnylam Pharmaceuticals and General Electric, along with academic distinction from the Tuck School of Business at Dartmouth and Boston College.

Thrilled to share my professional biography, which captures the arc of my 30+ year journey across life sciences, innovation, strategy, and global health. I’ve had the honor of collaborating with visionary leaders and organizations to unlock transformative value at the intersection of science, business, and impact.

Mary Hames is a seasoned Medical Affairs executive with a proven track record of leading high-performing teams and delivering strategic impact across rare disease, diagnostics, and oncology. With a foundation in biochemical genetics and over a decade of industry experience, she has played pivotal roles in clinical operations, launch preparedness, and cross-functional leadership. Known for her ability to navigate complex medical landscapes, Mary has successfully built and led medical teams, advanced companion diagnostics, and driven field strategy across multiple therapeutic areas. Her leadership is marked by scientific rigor, operational excellence, and a deep commitment to improving outcomes for patients with rare and life-threatening conditions.

Michael A. Pereira is a seasoned regulatory and quality executive with over three decades of experience guiding companies through the complex intersection of FDA compliance, global regulatory standards, and business operations. Known for his ability to build and remediate Quality Management Systems across diverse healthcare sectors—including drug, device, biologic, and combination products—Michael has led strategic initiatives for startups and global enterprises alike. With a rare ability to bridge technical and business teams, he brings clarity, structure, and strategic foresight to every challenge, earning a reputation as a trusted leader and advisor in highly regulated industries.

Brian Dakin, PMP, CIPM, is a seasoned leader in project management, data privacy, and technology solutions within the life sciences industry. As the Principal of Rhombus Consulting, he has driven strategic initiatives that enhance operational efficiency, regulatory compliance, and data governance for pharmaceutical and biotechnology organizations. In his role as President and Head of Operations for a trusted third-party entity, he has led efforts in patient de-identification, achieving HIPAA and SOC2 Type 2 compliance while increasing revenue and profitability. A thought leader and member of the Forbes Coaches Council, Brian also developed **On The Ball Theory**, a framework designed to help individuals unlock their potential and achieve meaningful personal and professional goals. His extensive experience, combined with his commitment to innovation and mentorship, has positioned him as an influential figure in both corporate leadership and personal development.